Direct amplification of the major outer membrane protein (MOMP) gene by polymerase chain
reaction (PCR) was used to identify Chlamydia trachomatis in eye swabs from clinically …

Background The presence of Chlamydia trachomatis (Ct) DNA at non-ocular sites suggests
that these sites may represent plausible routes of Ct transmission in trachoma. However …

Trachoma, the leading infectious cause of blindness worldwide, is an ancient human
disease. Its existence in China can be traced back to as early as the twenty-seventh century …

Background The clinical signs of active trachoma are often present in the absence of ocular
Chlamydia trachomatis infection, particularly following mass drug administration. Treatment …

Trachoma, the leading infectious cause of blindness, is caused by Chlamydia trachomatis
(Ct), a bacterium of the phylum Chlamydiae. Recent investigations revealed the existence of …

Background Blinding trachoma, caused by ocular infection with Chlamydia trachomatis, is
targeted for global elimination by 2020. Knowledge of risk factors can help target control …

Abstract Background Chlamydia trachomatis (Ct) plasmid has been shown to encode genes
essential for infection. We evaluated the population structure of Ct using whole-genome …

We studied the serovar distribution of Chlamydia trachomatis in patients with clinical eye
disease in Western Australia. Most disease occurred in indigenous communities and was …

Background Trachoma, the leading infectious cause of blindness worldwide, is caused by
conjunctival Chlamydia trachomatis infection. Trachoma is diagnosed clinically by …

ABSTRACT The Uppsala University Chlamydia trachomatis multilocus sequence type
(MLST) database (http://mlstdb. bmc. uu. se) is based on five target regions (non …